Omics Technologies in Cancer Biomarker Discovery
Regular price
€47.99
14 days return policy
Shipping & Delivery
A01=Xuewu Zhang
advanced omics biomarker identification
Age Group_Uncategorized
Age Group_Uncategorized
Amido Bond
Author_Xuewu Zhang
automatic-update
bioinformatics analysis
Breakpoint Cluster Region
Cancer Biomarker Discovery
Cancer Immunomics
Category1=Non-Fiction
Category=PS
Category=PSF
Ceramide Metabolism
clinical proteomics
COP=United Kingdom
D N A Methylation
DAB2IP
Delivery_Pre-order
Desorption Electrospray Ionization Mass Spectrometry
DNA Methylation
EGF Stimulation
EGFR Inhibitor Therapy
eq_bestseller
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
Estrogen Receptor Positive Breast Tumor
Hdl Cholesterol Level
Hereditary Papillary Renal Cell Carcinoma
Immuno Affinity Chromatography
Individualized Cancer Treatment
integrative genomics
Language_English
Linear Ion Trap
Mass Spectrometry Based Quantitative Proteomics
molecular diagnostics
Nuclear Magnetic Resonance
Omics Technologies
PA=Temporarily unavailable
Phosphopeptide Enrichment
Phosphopeptide Identification
phosphoprotein profiling
Price_€20 to €50
PS=Active
Quantitative Phosphoproteome Analysis
Sample Preparation
SNP Array
softlaunch
translational oncology
Product details
- ISBN 9781587063398
- Weight: 294g
- Dimensions: 152 x 229mm
- Publication Date: 10 Mar 2011
- Publisher: Taylor & Francis Ltd
- Publication City/Country: GB
- Product Form: Hardback
- Language: English
Secure
checkout
Fast Shipping
Easy returns
The early detection of human cancer is still one of the great challenges in the battle against this disease. Single biomarkers are not likely to provide sufficient diagnostic power and multibiomarker assays should be developed in order to reach high diagnostic accuracy for cancer screening at the population level. Omics technologies are emerging new biomarker discovery tools and have a high potential to yield panels of novel and cancer-specific biomarkers. This book provides an overview of recent studies aimed at the discovery of new cancer biomarkers through omics-based approaches, including genomics, transcriptomics, proteomics, metabonomics, peptidomics, phosphoproteomics, immunomics, glycoproteomics, lipidomics, bioinformatics and integrative omics technologies. The book serves as an introduction to researchers in the field and provides the platforms to facilitate the development of new approaches in cancer research.
Xuewu Zhang received his BSc in Mathematics in 1983 at Hunan Normal University, China. He got his MSc degree in Ecology in 1990 and PhD degree in Entomology in 1993, both from Zhongshan University, China. Then he worked at the Food Engineering Research Center of State Education Ministry, Zhongshan University, China. After May of 1998, he was invited to do postdoctoral research at several universities, including The University of Hong Kong, University of British Columbia (Canada), University of Manitoba (Canada) and University of California at Los Angeles (USA). In January of 2003, under the scheme “Admission of Talents, he returned to The University of Hong Kong as a Research Assistant Professor. In August o f2005, he joined the South China University of Technology as a Professor. Currently his main research interest focuses on target identification of biopharmaceuticals and nutraceuticals with omics technologies.
